Form 4: Roivant Sciences Director Sells Shares
Insider Transaction (Form 4)
Melissa B Epperly, a Director of Roivant Sciences Ltd., sold 4,938 shares of common stock on September 15, 2026.
Summary
- Open-market sale: disposed of 4,338 Common Shares at $39.65 ($172,002) on September 15, 2026; holds 10,500 after (Direct).
- Open-market sale: disposed of 600 Common Shares at $40.38 ($24,228) on September 15, 2026; holds 9,900 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $196,230 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Melissa B Epperly — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market sale | Common Shares | 4,338 | $40 | $172.0K | 10,500 |
| 2026-09-15 | Open-market sale | Common Shares | 600 | $40 | $24.2K | 9,900 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market sale (4,338 shares) |
| 2026-09-15 | Open-market sale (600 shares) |
Keywords
insider transaction, Form 4, ROIV, Roivant Sciences Ltd., bearish, Melissa B Epperly
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.